Literature DB >> 10191792

Maternal intrapartum temperature elevation as a risk factor for cesarean delivery and assisted vaginal delivery.

E Lieberman1, A Cohen, J Lang, F Frigoletto, L Goetzl.   

Abstract

OBJECTIVES: This study investigated the association of intrapartum temperature elevation with cesarean delivery and assisted vaginal delivery.
METHODS: Participants were 1233 nulliparous women with singleton, term pregnancies in vertex presentations who had spontaneous labors and were afebrile (temperature: 99.5 degrees F [37.5 degrees C]) at admission for delivery. Rates of cesarean and assisted vaginal deliveries according to highest intrapartum temperature were examined by epidural status.
RESULTS: Women with maximum intrapartum temperatures higher than 99.5 degrees F were 3 times as likely to experience cesarean (25.2% vs 7.2%) or assisted vaginal delivery (25.2% vs 8.5%). The association was present in epidural users and nonusers and persisted after birthweight, epidural use, and labor length had been controlled. In adjusted analyses, temperature elevation was associated with a doubling in the risk of cesarean delivery (odds ratio [OR] = 2.3, 95% confidence interval [CI] = 1.5, 3.4) and assisted vaginal delivery (OR = 2.1, 95% CI = 1.4, 3.1).
CONCLUSIONS: Modest temperature elevation developing during labor was associated with higher rates of cesarean and assisted vaginal deliveries. More frequent temperature elevation among women with epidural analgesia may explain in part the higher rates of cesarean and assisted vaginal deliveries observed with epidural use.

Entities:  

Mesh:

Year:  1999        PMID: 10191792      PMCID: PMC1508894          DOI: 10.2105/ajph.89.4.506

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  25 in total

1.  Cesarean delivery: a randomized trial of epidural versus patient-controlled meperidine analgesia during labor.

Authors:  S K Sharma; J E Sidawi; S M Ramin; M J Lucas; K J Leveno; F G Cunningham
Journal:  Anesthesiology       Date:  1997-09       Impact factor: 7.892

2.  Epidural analgesia and cesarean section for dystocia: risk factors in nulliparas.

Authors:  J A Thorp; L O Eckert; M S Ang; D A Johnston; A M Peaceman; V M Parisi
Journal:  Am J Perinatol       Date:  1991-11       Impact factor: 1.862

3.  Chorioamnionitis: a harbinger of dystocia.

Authors:  A J Satin; M C Maberry; K J Leveno; M L Sherman; D M Kline
Journal:  Obstet Gynecol       Date:  1992-06       Impact factor: 7.661

4.  The effect of continuous epidural analgesia on cesarean section for dystocia in nulliparous women.

Authors:  J A Thorp; V M Parisi; P C Boylan; D A Johnston
Journal:  Am J Obstet Gynecol       Date:  1989-09       Impact factor: 8.661

5.  A reevaluation of the association between instrument delivery and epidural analgesia.

Authors:  J L Hawkins; K R Hess; M A Kubicek; T H Joyce; D H Morrow
Journal:  Reg Anesth       Date:  1995 Jan-Feb

6.  Maternal pyrexia associated with the use of epidural analgesia in labour.

Authors:  L Fusi; P J Steer; M J Maresh; R W Beard
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

7.  The influence of anaesthetic techniques and type of delivery on peripartum serum interleukin-6 concentrations.

Authors:  R F De Jongh; E P Bosmans; M J Puylaert; W U Ombelet; H J Vandeput; R A Berghmans
Journal:  Acta Anaesthesiol Scand       Date:  1997-08       Impact factor: 2.105

8.  The effect of intrapartum epidural analgesia on nulliparous labor: a randomized, controlled, prospective trial.

Authors:  J A Thorp; D H Hu; R M Albin; J McNitt; B A Meyer; G R Cohen; J D Yeast
Journal:  Am J Obstet Gynecol       Date:  1993-10       Impact factor: 8.661

9.  Maternal temperature regulation during extradural analgesia for labour.

Authors:  W R Camann; L A Hortvet; N Hughes; A M Bader; S Datta
Journal:  Br J Anaesth       Date:  1991-11       Impact factor: 9.166

10.  Risk factors for fever in labor.

Authors:  A Herbst; P Wølner-Hanssen; I Ingemarsson
Journal:  Obstet Gynecol       Date:  1995-11       Impact factor: 7.661

View more
  8 in total

Review 1.  Epidural analgesia for childbirth: effects of newer techniques on neonatal outcome.

Authors:  Giorgio Capogna; Michela Camorcia
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 2.  Management of clinical chorioamnionitis: an evidence-based approach.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Eun Jung Jung; Ángel José Garcia Sánchez
Journal:  Am J Obstet Gynecol       Date:  2020-09-29       Impact factor: 8.661

3.  The effects of remifentanil or acetaminophen with epidural ropivacaine on body temperature during labor.

Authors:  Shmuel Evron; Tiberiu Ezri; Michael Protianov; Gleb Muzikant; Oscar Sadan; Amir Herman; Peter Szmuk
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

Review 4.  Temperature monitoring and perioperative thermoregulation.

Authors:  Daniel I Sessler
Journal:  Anesthesiology       Date:  2008-08       Impact factor: 7.892

Review 5.  Hyperthermia after epidural analgesia in obstetrics.

Authors:  C J Mullington; S Malhotra
Journal:  BJA Educ       Date:  2020-10-21

6.  Remifentanil patient-controlled versus epidural analgesia on intrapartum maternal fever: a systematic review and meta-analysis.

Authors:  Guolin Lu; Wenshui Yao; Xiaofen Chen; Sujing Zhang; Min Zhou
Journal:  BMC Pregnancy Childbirth       Date:  2020-03-12       Impact factor: 3.007

7.  Consistency and timeliness of intrapartum care interventions as predictors of intrapartum stillbirth in public health facilities of Addis Ababa, Ethiopia: a case-control study.

Authors:  Alemayehu Gebremariam Agena; Lebitsi Maud Modiba
Journal:  Pan Afr Med J       Date:  2021-09-14

8.  Suspected clinical chorioamnionitis with peak intrapartum temperature <380C: the prevalence of confirmed chorioamnionitis and short term neonatal outcome.

Authors:  Anvar Paraparambil Vellamgot; Khalil Salameh; Lina Hussain M Habboub; Rajesh Pattuvalappil; Naser Abulgasim Elkabir; Yousra Shehada Siam; Hakam Khatib
Journal:  BMC Pediatr       Date:  2022-04-11       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.